XML 37 R28.htm IDEA: XBRL DOCUMENT v3.26.1
Segment Disclosures (Tables)
6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of Revenue and Expenses

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

 

(in thousands)

 

 

(in thousands)

 

Total revenue

 

$

1,418

 

 

$

18,658

 

 

$

11,677

 

 

$

69,575

 

External costs incurred by product candidate (target):

 

 

 

 

 

 

 

 

 

 

 

 

Varseta-M (EpCAM)

 

 

6,225

 

 

 

3,679

 

 

 

14,039

 

 

 

7,949

 

CX-801 (IFNα2b)

 

 

437

 

 

 

452

 

 

 

781

 

 

 

940

 

CX-904 (EGFRxCD3)

 

 

227

 

 

 

(550

)

 

 

468

 

 

 

561

 

Other wholly owned and partnered programs

 

 

272

 

 

 

498

 

 

 

415

 

 

 

894

 

General research and development expenses

 

 

1,925

 

 

 

1,520

 

 

 

4,808

 

 

 

4,050

 

 Total external costs

 

 

9,086

 

 

 

5,599

 

 

 

20,511

 

 

 

14,394

 

 Internal costs

 

 

8,512

 

 

 

7,723

 

 

 

16,325

 

 

 

17,795

 

 Research and development expenses

 

 

17,598

 

 

 

13,322

 

 

 

36,836

 

 

 

32,189

 

General and administrative expenses

 

 

7,601

 

 

 

6,622

 

 

 

18,294

 

 

 

16,050

 

Total operating expenses

 

 

25,199

 

 

 

19,944

 

 

 

55,130

 

 

 

48,239

 

Income (loss) from operations

 

 

(23,781

)

 

 

(1,286

)

 

 

(43,453

)

 

 

21,336

 

Interest income

 

 

3,157

 

 

 

1,178

 

 

 

4,647

 

 

 

2,133

 

Other income

 

 

18

 

 

 

17

 

 

 

11

 

 

 

28

 

Income (loss) before income taxes

 

 

(20,606

)

 

 

(91

)

 

 

(38,795

)

 

 

23,497

 

Provision for income taxes

 

 

60

 

 

 

63

 

 

 

119

 

 

 

126

 

Net income (loss)

 

$

(20,666

)

 

$

(154

)

 

$

(38,914

)

 

$

23,371